- BusinessYahoo Finance
A nationwide closure would be crushing for the company, crippling its distribution network amid a spike in demand for Amazon’s delivery service.
"That’s what I try to not focus on because it scares me," the CNN host said during the latest update on his condition.
(Bloomberg Opinion) -- Here's one more issue to add to the bonfire of tensions with China brought on by the coronavirus pandemic. The country is reportedly reopening its wet markets, the fresh produce stalls associated with Covid-19's early spread in Wuhan.It's understandable that countries now in the grip of the first wave of infection might be outraged. Many blame wet markets for starting the outbreak in the first place. Opening them again, at a moment when thousands are dying overseas, seems emblematic of Beijing's increasingly chauvinistic approach to world affairs.Animals in wet markets are penned and slaughtered or sold live right next to stalls selling fruit and vegetables. Conditions, as my colleague Adam Minter has written, are often less than hygienic.Places where a range of common and exotic animals mix together while bodily fluids flow freely may seem a fertile breeding ground for the virulent novel diseases that cross the species barrier to humans and occasionally become pandemics.At the same time, let’s put the outrage on pause. Wet markets are increasingly losing ground to supermarkets in China. If they're showing resilience as suppliers of fresh goods, it's precisely because consumers regard them as a healthier and more sustainable alternative.That perception isn't inaccurate. The prevalence of food-borne microbial illness in developing East Asia suggests that far from being cesspits of disease, wet markets do a good job of providing households with clean, fresh produce. And while the origins of coronavirus remain obscure, they may have at least as much to do with more worldwide activities such as intensive farming as practices specific to Asia.The attraction of wet markets isn't so different from that of farmers’ markets in Western countries. In contrast to a supermarket model where multiple layers of retailers, wholesalers and logistics companies stand in between the consumer and the grower, wet markets offer a personal and direct connection between shopper, stallholder and farmer.Consumers know the food is fresh because there's generally little refrigeration, so everything must be sold on the day. If in doubt, they can ask the stallholder what's in season and which produce is best at the moment. If they think one market looks unsanitary, they can choose to shop at another.That helps explain how wet markets have managed to hold their own in spite of the growth of store-based retail in recent years. Supermarkets now account for about half of all grocery spending in China, up from about 36% in 1995, according to Euromonitor International. Add in convenience stores and the like and so-called modern grocery has about 68% of China's retail wallet, giving wet markets less than a third.Still, that store-based spending is overwhelmingly concentrated in packaged, rather than fresh produce. Foreign retailers that once hoped to dominate China's staple goods sector such as Carrefour SA and Metro AG have struggled and sold out of local ventures — but wet markets are still going strong.The evidence suggests this consumer loyalty isn’t misplaced. One 2015 study for the World Health Organization compared the number of years of life lost per 100,000 people due to food-borne sickness, disability and death. The region encompassing the wet market zone from China and South Korea down through most of Southeast Asia has the best record for microbial infections outside the Americas, Europe and the rich countries of the Pacific Rim.(1)What about Covid-19 itself, though? There's good evidence that the virus has genetic characteristics from another pathogen found in pangolins, an exotic mammal sometimes sold in Chinese markets. And it circulated extensively around one of Wuhan's seafood and meat markets last December, although the earliest infections don't seem to have been connected to the site.Only a small minority of wet markets sell such exotica, though, so you can close down the wild animal trade without shutting the places where most Chinese people get their daily sustenance. And don't overlook the possibility that a key ingredient in Covid-19's genetic cocktail isn’t wild game, but domesticated livestock. The high-density conditions on farms are far more conducive to cooking up novel diseases, as we've written — and even pangolins are farmed in China these days.To the extent that the mix of the raw and the cooked in Asia's wet markets is a health problem, it can easily be mitigated by better building design (such as separating meat, vegetable and livestock areas and keeping markets fully enclosed), plus the sort of mandated cleaning regulations found in places like Singapore, Hong Kong and South Korea.There's plenty to complain about in the way that China downplayed and hushed up the initial outbreak until it was all but inevitable it would become a worldwide pandemic. Closing all wet markets, though, isn't the solution. (1) Indeed, the data suggest the problem with Asia's appetite for "warm meat" isn't that fresh-slaughtered produce is less healthy than the chilled meat from an abattoir, but that local preferences for undercooked meat and fish lead to unusually high burdens of tapeworms, flukes and other parasitic worms. That's not something different retail formats can solve.This column does not necessarily reflect the opinion of Bloomberg LP and its owners.David Fickling is a Bloomberg Opinion columnist covering commodities, as well as industrial and consumer companies. He has been a reporter for Bloomberg News, Dow Jones, the Wall Street Journal, the Financial Times and the Guardian.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
- LifestyleMartha Stewart Living
For Kitty's needs and your sense of home style, these beautifully designed structures are every bit as attractive as they are functional.
As the number of coronavirus cases remains on the rise, researchers at the University of Pittsburgh School of Medicine and UPMC are working on a possible vaccine for SARS-CoV-2, the virus that causes COVID-19. Scientists announced news of the potential vaccine, which has now been tested successfully on mice, on Thursday.According to a press release from UPMC and the university, “When tested in mice, the vaccine, delivered through a fingertip-sized patch, produces antibodies specific to SARS-CoV-2 at quantities thought to be sufficient for neutralizing the virus.” In a paper announcing the vaccine in the journal EBioMedicine, co-author Andrea Gambotto, an associate professor of surgery at the university said the researchers hope to “get this into patients as soon as possible.” Through their previous work on SARS-CoV in 2003 and MERS-CoV in 2014, researchers and scientists in that lab have learned that a spike protein is of particular importance to building immunity against the virus. Thanks to that research, Gambotto said, “We knew exactly where to fight this new virus.”The announcement comes as we enter the fourth month of the pandemic, with one-third of the global population now on lockdown trying to fight the spread of the virus through social distancing. While that strategy is working to flatten the curve in places that adopted the practice early on, the full effects of the virus are yet to be seen in places that waited to enforce stay-at-home orders. The novel coronavirus has now infected more than one million people globally and killed more than 54,000 people. The U.S. alone has reported more than 245,500 of those cases, with hotbeds for the virus in New Orleans, Chicago, New York, Seattle, and Detroit. Still, even as we take the necessary social precautions to slow the spread of coronavirus, only a vaccine can help people build immunity to it and prevent people from getting sick. There are currently at least 35 companies and academic institutions working to do so, four of which have developed vaccines that are in the animal-testing stages, The Guardian reports. Last month, researchers at the University of Pittsburgh estimated it could take at least a year to 18 months to develop a vaccine and get through the trial period. According to Louis Falo, a professor and chairman of the Department of Dermatology at the University of Pittsburgh who co-authored the paper in EBioMedicine, they would like to start clinical trials in about a month, “give or take. Maybe two months. We just started the process.”Like what you see? How about some more R29 goodness, right here?I Tested The New Coronavirus VaccineThe C3 Test Can Diagnose People Without SymptomsCDC To Change Their Face Mask Recommendations
- HealthHuffPost Life
A study gives us some clues on whether COVID-19 can be transmitted through the air and how long it lingers.